Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Reed

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Annals of the Rheumatic Diseases|February 2, 2012
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registryJeffrey D Greenberg, George Reed, Dennis Decktor, et al.
The Journal of Infectious Diseases|April 4, 2002
Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virusPeter F Wright, William C Gruber, Melissa Peters, et al.
Circulation. Cardiovascular Quality and Outcomes|July 8, 2010
Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism StudyFrederick A Spencer, Robert J Goldberg, Darleen Lessard, et al.
Journal of Thrombosis and Thrombolysis|July 25, 2009
Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE studyFrederick A Spencer, Cathy Emery, Samuel W Joffe, et al.
BMC Health Services Research|June 7, 2011
Design and methods for a randomized clinical trial comparing three outreach efforts to improve screening mammography adherenceMary E Costanza, Roger Luckmann, Mary Jo White, et al.
Arthritis Care & Research|September 22, 2025
Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced PatientsMisti L Paudel, Nancy Shadick, Michael Weinblatt, et al.
Clinical and Experimental Rheumatology|January 9, 2013
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapiesKhaled Sarsour, Jeffrey Greenberg, Joseph A Johnston, et al.
The Journal of Rheumatology|September 12, 2008
Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA databaseVeena K Ranganath, Harold E Paulus, Alina Onofrei, et al.
Arthritis Care & Research|May 29, 2015
Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic DrugsDimitrios A Pappas, Michele M Hooper, Joel M Kremer, et al.
Elife|February 6, 2016
Layer specific and general requirements for ERK/MAPK signaling in the developing neocortexLei Xing, Rylan S Larsen, George Reed Bjorklund, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Annals of the Rheumatic Diseases|February 2, 2012
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registryJeffrey D Greenberg, George Reed, Dennis Decktor, et al.
The Journal of Infectious Diseases|April 4, 2002
Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virusPeter F Wright, William C Gruber, Melissa Peters, et al.
Circulation. Cardiovascular Quality and Outcomes|July 8, 2010
Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism StudyFrederick A Spencer, Robert J Goldberg, Darleen Lessard, et al.
Journal of Thrombosis and Thrombolysis|July 25, 2009
Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE studyFrederick A Spencer, Cathy Emery, Samuel W Joffe, et al.
BMC Health Services Research|June 7, 2011
Design and methods for a randomized clinical trial comparing three outreach efforts to improve screening mammography adherenceMary E Costanza, Roger Luckmann, Mary Jo White, et al.
Arthritis Care & Research|September 22, 2025
Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced PatientsMisti L Paudel, Nancy Shadick, Michael Weinblatt, et al.
Clinical and Experimental Rheumatology|January 9, 2013
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapiesKhaled Sarsour, Jeffrey Greenberg, Joseph A Johnston, et al.
The Journal of Rheumatology|September 12, 2008
Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA databaseVeena K Ranganath, Harold E Paulus, Alina Onofrei, et al.
Arthritis Care & Research|May 29, 2015
Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic DrugsDimitrios A Pappas, Michele M Hooper, Joel M Kremer, et al.
Elife|February 6, 2016
Layer specific and general requirements for ERK/MAPK signaling in the developing neocortexLei Xing, Rylan S Larsen, George Reed Bjorklund, et al.
Pageof 14